AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « receiving »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
receiver < receiving < recent  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]
Ident.Authors (with country if any)Title
000020 (2011) Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
000033 (2010) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Noriho Sakamoto [Japon] ; Yuji Ishimatsu [Japon] ; Katsumi Eguchi [Japon]A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
000083 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000094 (2011) Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
000123 (2015) Tamara O. Thomas [États-Unis] ; Shanmuganathan Chandrakasan [États-Unis] ; Maureen O'Brien [États-Unis] ; John L. Jefferies [États-Unis] ; Thomas D. Ryan [États-Unis] ; Ivan Wilmot [États-Unis] ; Michael L. Baker [États-Unis] ; Peace C. Madueme [États-Unis] ; David Morales [États-Unis] ; Angela Lorts [États-Unis]The use of a Berlin Heart EXCOR LVAD in a child receiving chemotherapy for Castleman's disease
000365 (2013) M. Kostine ; T. Barnetche ; E. Ardouin ; M. Joly [France] ; E. Rabois [France] ; B. Glace [France] ; T. Schaeverbeke ; C. RichezFRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis?
000423 (2013) E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie]FRI0184 Postoperative complications in rheumatoid arthritis patients receiving biologic and nonbiologic disease-modifying antirheumatic drugs
000459 (2013) N. Mozaffarian [États-Unis] ; M. Karunaratne [États-Unis] ; V. Arora [États-Unis]SAT0444 Administration of Routine Preventative Vaccinations in Children with Juvenile Idiopathic Arthritis Receiving Adalimumab
000518 (2013) K. Nishimura [Japon] ; R. Sakai [Japon] ; T. Kondo [Japon] ; T. Kurasawa [Japon] ; A. Okuyama [Japon] ; E. Nishi [Japon] ; Y. Shirai [Japon] ; H. Takei [Japon] ; H. Nagasawa [Japon] ; K. Amano [Japon]AB0549 Discontinuation of methotrexate (MTX) in rheuamtoid arthritis (RA) patients receiving tocilizumab (TCZ)
000553 (2013) V. Strand [États-Unis] ; M. Genovese [États-Unis] ; U. Mallya [États-Unis] ; H. Richards [Suisse] ; S. Mpofu [Suisse]AB0582 Improvements in health-related quality of life (HRQOL) in patients with rheumatoid arthritis (RA) receiving secukinumab: Results of a dose-finding study
000571 (2013) Y. Kanayama ; T. Kojima ; Y. Hirano ; N. Takahashi ; K. Funahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; Y. Oishi ; N. IshiguroAB0585 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving tocilizumab treatment from japanese tbc registry
000572 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; T. Shioura ; N. Asai ; T. Kobayakawa ; K. Saito [Japon] ; N. IshiguroAB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry
000582 (2013) Y. Kanayama ; T. Kojima ; Y. Hirano ; Y. Yabe [Japon] ; N. Takahashi ; K. Funahashi ; Y. Oishi ; N. IshiguroAB0336 Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving tocilizumab treatment comparison with infliximab treatment from japanese tbcr
000620 (2013) E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie]AB0311 Postoperative complications in rheumatoid arthritis patients receiving rituximab and conventional disease-modifying antirheumatic drugs (dmards)
000636 (2013) M. Bodro [Espagne, Australie] ; D. L. Paterson [Australie]Listeriosis in patients receiving biologic therapies
000705 (2006) J. Ogawa [Japon] ; M. Harigai [Japon] ; T. Akashi [Japon] ; K. Nagasaka [Japon] ; F. Suzuki [Japon] ; S. Tominaga [Japon] ; N. Miyasaka [Japon]Exacerbation of chronic active Epstein–Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody
000748 (2012) Ariel C. Bulua [États-Unis] ; Douglas B. Mogul [États-Unis] ; Ivona Aksentijevich [États-Unis] ; Harjot Singh [États-Unis] ; David Y. He [États-Unis] ; Larry R. Muenz [États-Unis] ; Michael M. Ward [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Daniel L. Kastner [États-Unis] ; Richard M. Siegel [États-Unis] ; Keith M. Hull [États-Unis]Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study
000805 (2013) F. Speth [Allemagne] ; N. Wellinghausen [Allemagne] ; J.-P. Haas [Allemagne]Medikamentöse Prophylaxe während intensivierter Immunsuppression bei Kindern und Jugendlichen
000813 (2013) D. Humme [Allemagne] ; M. Beyer [Allemagne] ; H.-J. Röwert-Huber [Allemagne] ; W. Sterry [Allemagne] ; S. Philipp [Allemagne]CD30-positives anaplastisch großzelliges T-Zell-Lymphom unter immunsuppressiver Therapie einer Pityriasis rubra pilaris mit Ustekinumab
000875 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000883 (2016) Prativa S. A. Jayasekera [Royaume-Uni] ; Maeve L. Walsh [Royaume-Uni] ; Daniel Hurrell [Royaume-Uni] ; Richard A. G. Parslew [Royaume-Uni]Case Report of Lichen Planopilaris Occurring in a Pediatric Patient Receiving a Tumor Necrosis Factor α Inhibitor and a Review of the Literature

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "receiving" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "receiving" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    receiving
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021